Psilocybin | MJ Shareholders

MagicMed Shortcuts Commercialization Timeline with University Agreement

November 4, 2020

Ryan Allway November 4th, 2020 App, Exclusive, Psychedelics, Top Story Most pharmaceutical and biotech investors are familiar with long commercialization timelines, but there are a few ways to shortcut the process. For example, the Food and Drug Administration provides Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review designations... Read more

MagicMed Closes Oversubscribed $1.6M Private Placement to Build Out Its Psybrary™

September 21, 2020

Ryan Allway September 21st, 2020 App, Psychedelics, Top Story The burgeoning psychedelics sector in many ways resembles the cannabis industry of a decade ago. With rising interest in psychedelic medicine, analysts project that the market could grow at a 16.3% compound annual growth rate to $6.85 billion by 2027.... Read more

Psychedelics: Investing in the Perfect BrainStorm

April 3, 2020

Ryan Allway April 3rd, 2020 App, Exclusive, News, Top Story Psychedelics are rapidly becoming both a mainstream treatment option and investment opportunity. With growing interest among researchers, forward-thinking companies are starting to build a presence in the space. In this article, we will take a look at the growing... Read more

5 Ways to Participate in the Psychedelics Boom

March 27, 2020

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more

The Effort to Decriminalize Psilocybin in California is Underway

California Uncategorized February 24, 2020

Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver, and Santa Cruz have decriminalized psilocybin to varying degrees. Much like cannabis, public perception of certain psychedelics like psilocybin is shifting rapidly, as people really the incredible…

The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)

Uncategorized February 20, 2020

There is a bona fide movement underway with psilocybin. Decriminalization occurred last year in Denver, Oakland and Santa Cruz, and that was just a start: nearly 100 other cities are looking at decriminalizing psychedelics. At the state level, ballot measures are out for signature in California and Oregon. Federally, legislation has been proposed to allow…

USPTO Grants Trademark for PSILOCYBIN, But Don’t Get Too Worked Up Yet

Uncategorized February 5, 2020

A few weeks back, Twitter was abuzz about the fact that the United State Patent and Trademark Office (“USPTO”) granted a federal trademark registration for the word PSILOCYBIN. The mark was registered by the company Black Pandas LLC and applies to the following services in Class 041: “Development and dissemination of education materials of others…

This Psilocybin Patent Could Be a Really Big Deal

Uncategorized January 22, 2020

Last week, COMPASS Pathways announced its acquisition of US Patent No 10,591,175. What does that patent cover? Psilocybin! More specifically, COMPASS has locked down “methods of treating drug-resistant depression with a psilocybin formulation.” The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post…